You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 139 No. 11, November 1985 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Gentamicin vs Cefotaxime for Therapy of Neonatal Sepsis

Relationship to Drug Resistance

Charles S. Bryan, MD; Joseph F. John, Jr, MD; M. Sharada Pai, MD; Tom L. Austin, MD

Am J Dis Child. 1985;139(11):1086-1089.


Abstract

• An outbreak of serious infections due to gentamicin-resistant Klebsiella pneumoniae occurred in a neonatal intensive care unit in which the combination of gentamicin sulfate and ampicillin sodium had been used for standard initial therapy for suspected sepsis for nearly 11 years. After institution of control measures that included the substitution of cefotaxime sodium for gentamicin in the standard regimen, the outbreak promptly subsided. Nevertheless, a second outbreak of serious infections due to cefotaxime-resistant Enter-obacter cloacae began ten weeks later. Sequential stool cultures from patients in the unit confirmed the disappearance of gentamicin-resistant K pneumoniae and the emergence of cefotaxime-resistant E cloacae after the change in antibiotic policy. These observations suggest that routine use of newer cephalosporins for therapy of suspected sepsis may lead to the emergence of drugresistant microorganisms more rapidly than has occurred with the aminoglycosides.

(AJDC 1985;139:1086-1089)



Author Affiliations

From the Departments of Medicine (Dr Bryan) and Pediatrics (Drs Pai and Austin), University of South Carolina School of Medicine and Richland Memorial Hospital, Columbia; and the Department of Medicine, Medical University of South Carolina and Veterans Administration Medical Center, Charleston (Dr John).


Footnotes

Reprint requests to Richland Memorial Hospital, ACC2, Columbia, SC 29203 (Dr Bryan).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Evaluation and Treatment of Neonates With Suspected Late-Onset Sepsis: A Survey of Neonatologists' Practices
Rubin et al.
Pediatrics 2002;110:e42-42.
ABSTRACT | FULL TEXT  

Enterobacter Bacteremia: Clinical Features and Emergence of Antibiotic Resistance during Therapy
Chow et al.
ANN INTERN MED 1991;115:585-590.
ABSTRACT  

New {beta}-Lactams: New Problems for the Internist
Sanders
ANN INTERN MED 1991;115:650-651.
ABSTRACT  

Drug Therapy in Neonatal Sepsis
Phillips and Kaplan
Journal of Pharmacy Practice 1989;2:28-35.
ABSTRACT  

Review Article: Update on Bacterial Meningitis
Kaplan and Fishman
J Child Neurol 1988;3:82-93.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.